These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22247099)

  • 1. Alopecia areata associated with haloperidol decanoate long-acting injection.
    Bhattacharya A; Roy D; Hazarika S; Das S; Nath K; Saddichha S
    Aust N Z J Psychiatry; 2012 Jan; 46(1):69. PubMed ID: 22247099
    [No Abstract]   [Full Text] [Related]  

  • 2. Dosage strategies with long-acting injectable neuroleptics, including haloperidol decanoate.
    Kane JM
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):20S-23S. PubMed ID: 2870088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection site reactions after intramuscular administration of haloperidol decanoate 100 mg/mL.
    Hamann GL; Egan TM; Wells BG; Grimmig JE
    J Clin Psychiatry; 1990 Dec; 51(12):502-4. PubMed ID: 1979555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol decanoate: injection site reactions.
    Maharaj K; Guttmacher LB; Moeller R
    J Clin Psychiatry; 1995 Apr; 56(4):172-3. PubMed ID: 7713859
    [No Abstract]   [Full Text] [Related]  

  • 5. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
    arap Mengech HN; Wazome EG
    East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
    [No Abstract]   [Full Text] [Related]  

  • 6. [Accidental intravenous administration of haloperidol decanoate].
    Heinz P
    Psychiatr Prax; 1996 Jan; 23(1):42. PubMed ID: 8851235
    [No Abstract]   [Full Text] [Related]  

  • 7. Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration.
    Legras A; Hurel D; Dabrowski G; Grenet D; Graveleau P; Loirat P
    Am J Med; 1988 Dec; 85(6):875-8. PubMed ID: 2904226
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
    Möller HJ; Kissling W
    Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
    [No Abstract]   [Full Text] [Related]  

  • 11. Longterm maintenance therapy with depot haloperidol in schizophrenia.
    Zbytovský J
    Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
    [No Abstract]   [Full Text] [Related]  

  • 12. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate.
    Youssef HA
    Clin Neuropharmacol; 1991; 14 Suppl 2():S16-21; discussion S22-3. PubMed ID: 1684308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of alopecia areata induced by zotepine.
    Kubota T; Ishikura T; Jibiki I
    Acta Neurol (Napoli); 1993 Jun; 15(3):200-3. PubMed ID: 7901970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection site reactions.
    Hay J
    J Clin Psychiatry; 1992 Jul; 53(7):256. PubMed ID: 1353493
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the efficacy of haloperidol decanoate].
    Alvarez JV; Li Gambi M
    Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol decanoate: a depot antipsychotic.
    Hemstrom CA; Evans RL; Lobeck FG
    Drug Intell Clin Pharm; 1988 Apr; 22(4):290-5. PubMed ID: 2897276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol decanoate in children.
    Alessi N; Alkhouri I; Fluent T; Quinlan P; Williams K
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):865-6. PubMed ID: 11501680
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple Long-Acting Injectable Antipsychotics for Treatment-Resistant Schizophrenia: Case Report.
    Scangos KW; Caton M; Newman WJ
    J Clin Psychopharmacol; 2016 Jun; 36(3):283-5. PubMed ID: 27035492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.